Pharmacologic Treatment of Postpartum Women With New-Onset Major Depressive Disorder: A Randomized Controlled Trial With Paroxetine
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Approximately 6% to 8% of postpartum women suffer from major depressive disorder (MDD), but only a few controlled trials have investigated the efficacy of pharmacologic treatments. The current study determined the relative efficacy of paroxetine compared to placebo in the treatment of acute postpartum MDD. METHOD: This was an 8-week, multicenter, parallel, placebo-controlled trial of paroxetine for treatment of postpartum depression. Subjects were eligible if they had an onset of DSM-IV MDD after, but within 3 months of, delivery and had a minimum score of 16 on the 17-item Hamilton Rating Scale for Depression (HAM-D-17) at intake. Seventy women were randomly assigned to either immediate-release paroxetine or matching placebo, and 31 completed the trial. Subjects were reassessed with the HAM-D-17, the Inventory of Depressive Symptomatology-Self-Report (IDS-SR) form and the Clinical Global Impressions (CGI) scales. The study was conducted between 1997 and 2004. RESULTS: Both groups improved over time and did not differ significantly on the HAM-D-17 or IDS-SR at follow-up. However, greater improvement in overall mean +/- SD clinical severity was found for the paroxetine (Clinical Global Impressions-Severity of Illness [CGI-S] score = 1.8 +/- 1.4) compared with the control group (CGI-S score = 3.1 +/- 1.4; p = .05). The paroxetine group also had a significantly higher rate of remission, compared to the placebo group (37% vs. 15%, odds ratio = 3.5, 95% CI = 1.1 to 11.5). The rate of adverse effects did not differ significantly between groups. CONCLUSION: Study results were limited by lower than expected enrollment and higher than anticipated attrition. Nonetheless, paroxetine treatment was associated with a significantly higher rate of remission among women with postpartum onset of MDD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Antidepressants can effectively decrease PPD symptoms (e.g., Cohen et al. 2001; Wisner et al. 2002; Yonkers et al. 2008)”
From Perinatal Dyadic Psychotherapy for postpartum depression: a randomized controlled pilot trial (2015) · cites this paper as Yonkers et al. 2008
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1992) · PubMed · Cited by 33,716
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
(1976) · Medical Entomology and Zoology · Cited by 8,899
Perinatal Depression: A Systematic Review of Prevalence and Incidence
Gavin, N. I., Gaynes, B. N., Lohr, K. N., Meltzer-Brody, S., Gartlehner, G., & Swinson, T. (2005) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000183597.31630.db · Cited by 3,282
Rates and risk of postpartum depression – a meta-analysis
O'hara, M. W., & Swain, A. M. (1996) · International Review of Psychiatry · doi:10.3109/09540269609037816 · Cited by 3,116
The Inventory of Depressive Symptomatology (IDS): Psychometric properties
Rush, A. J., Gullion, C. M., Basco, M. R., Jarrett, R. B., & Trivedi, M. H. (1996) · Psychological Medicine · doi:10.1017/s0033291700035558 · Cited by 2,177
Russo, J., Trujillo, C. A., Wingerson, D., Decker, K., Ries, R., Wetzler, H., & Roy-Byrne, P. (1998) · Medical Care · doi:10.1097/00005650-199805000-00015 · Cited by 1,308
Transdermal oestrogen for treatment of severe postnatal depression
Gregoire, A. J. P., Kumar, R., Everitt, B., & Studd, J. W. W. (1996) · The Lancet · doi:10.1016/s0140-6736(96)91414-2 · Cited by 562
Appleby, L., Warner, R., Whitton, A., & Faragher, B. (1997) · BMJ · doi:10.1136/bmj.314.7085.932 · Cited by 559
Cooper, P. J., & Murray, L. (1995) · British Journal of Psychiatry · doi:10.1192/bjp.166.2.191 · Cited by 452
Research works printed but not linked: 3
- [10]First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for Axis I DSM-IV disorders -patient edition (SCID-I/P, Version 2.0) 1994. [Google Scholar]
- [13]Weissman MM, Paykel ES, Prusoff BA. Social adjustment scale handbook-rationale, reliability, validity, scoring and training guide. 1994. [Google Scholar]
- [14]Ware JE, Sherbourne CD. The MOS 36-item short-form health survey. Medical Care. 1992;30:473–481. [PubMed] [Google Scholar]
Cited by
Postpartum depression: current status and future directions
O'Hara, M. W., & McCabe, J. E. (2013) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-050212-185612 · Cited by 1,750
“There were no differences between groups on clinical and self-report measures of depression; however, the Clinical Global Impressions-Severity of Illness Scale did show a significant effect in favor of the paroxetine condition (Yonkers et al. 2008).”
ResultPRACTICE GUIDELINE FOR THE Treatment of Patients With Major Depressive Disorder
Gelenberg, A. J., Freeman, P. B., Markowitz, J. C., Rosenbaum, J. F., Thase, M. E., Trivedi, M. H., & Rhoads, R. S. (2010) · Cited by 1,520
Kennedy, S. H., Lam, R. W., Parikh, S. V., Patten, S. B., & Ravindran, A. V. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.06.043 · Cited by 525
Pearlstein, T., Howard, M., Salisbury, A., & Zlotnick, C. (2009) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2008.11.033 · Cited by 462
Sex differences in depression: Insights from clinical and preclinical studies
Eid, R. S., Gobinath, A. R., & Galea, L. A. M. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.01.006 · Cited by 457
Lam, R. W., Kennedy, S. H., Grigoriadis, S., McIntyre, R. S., Milev, R., Ramasubbu, R., Parikh, S. V., Patten, S. B., & Ravindran, A. V. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.06.041 · Cited by 431
“, 2004), while another found that paroxetine was superior to placebo in achieving remission (Yonkers et al., 2008).”
A meta-analysis of treatments for perinatal depression
Sockol, L. E., Epperson, C. N., & Barber, J. P. (2011) · Clinical Psychology Review · doi:10.1016/j.cpr.2011.03.009 · Cited by 287
Nillni, Y. I., Mehralizade, A., Mayer, L., & Milanovic, S. (2018) · Clinical Psychology Review · doi:10.1016/j.cpr.2018.06.004 · Cited by 207
Cooper, M. C., Kilvert, H. S., Hodgkins, P., Roskell, N. S., & Eldar-Lissai, A. (2019) · CNS Drugs · doi:10.1007/s40263-019-00672-w · Cited by 192
Antidepressant treatment for postnatal depression
Molyneaux, E., Howard, L. M., McGeown, H. R., Karia, A. M., & Trevillion, K. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002018.pub2 · Cited by 171
Treatment of post-partum depression: a review of clinical, psychological and pharmacological options
Leight, K., Fitelson, Kim, S., & Baker, A. (2010) · International Journal of Women's Health · doi:10.2147/ijwh.s6938 · Cited by 163
Biological Aspects of Postpartum Depression
Skalkidou, A., Hellgren, C., Comasco, E., Sylvén, S., & Poromaa, I. S. (2012) · Women's Health · doi:10.2217/whe.12.55 · Cited by 157
“The most solid evidence for a serotonergic involve ment is the beneficial effect of selective serotonin reuptake inhibitors (SSRI) for the treatment of PPD, although some of the smaller studies have failed to demonstrate a beneficial effect in com parison with other types of interventions [62–67].”
BackgroundPharmacotherapy of Postpartum Depression: Current Approaches and Novel Drug Development
Frieder, A., Fersh, M., Hainline, R., & Deligiannidis, K. M. (2019) · CNS Drugs · doi:10.1007/s40263-019-00605-7 · Cited by 156
Lau, Y., Wang, Y., Yin, L., Chan, K. S., & Guo, X. (2010) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2010.02.005 · Cited by 150
“, 2005) despite its serious consequences and the availability of highly effective pharmacologic and non-pharmacologic therapies (Milgrom et al., 2005; Yonkers et al., 2008).”
BackgroundThe effects of mother–infant singing on emotional closeness, affect, anxiety, and stress hormones
Fancourt, D., & Perkins, R. (2018) · Music & Science · doi:10.1177/2059204317745746 · Cited by 136
Kroska, E. B., & Stowe, Z. N. (2020) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2020.05.001 · Cited by 136
Batt, M. M., Duffy, K. A., Novick, A. M., Metcalf, C. A., & Epperson, C. N. (2020) · Focus · doi:10.1176/appi.focus.20190045 · Cited by 129
De Crescenzo, F., Perelli, F., Armando, M., & Vicari, S. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.09.019 · Cited by 114
“, 2006), paroxetine (Misri et al., 2004; Yonkers et al., 2008), while various antidepressants, for most SSRIs, were used in the RESPOND trial (Sharp et al.”
BackgroundMethodResultInfluentialOxytocin and postpartum depression: Delivering on what's known and what's not
Kim, S., Soeken, T. A., Cromer, S. J., Martinez, S. R., Hardy, L. R., & Strathearn, L. (2014) · Brain Research · doi:10.1016/j.brainres.2013.11.009 · Cited by 118
Perinatal depression: treatment options and dilemmas
Pearlstein, T. (2008) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0829 · Cited by 107
“Postpartum blues occur in 15%–85% of women, peaking at day 5 and usually resolving by days 7–10.150 In addition to mood swings, irritability, tearfulness, fatigue and confusion, mild hypomanic symptoms and elation may also occur.150–152 A review of risk factors for postpartum blues suggested that neuroticism, depressi…”
InfluentialAntidepressant treatment for postnatal depression
Brown, J. V. E., Wilson, C. A., Ayre, K., Robertson, L., South, E., Molyneaux, E., Trevillion, K., Howard, L. M., & Khalifeh, H. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013560.pub2 · Cited by 175
Milgrom, J., Gemmill, A. W., Ericksen, J., Burrows, G., Buist, A., & Reece, J. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867414565474 · Cited by 94
“A handful of small, placebo-controlled randomised trials have confirmed clinical effects for specific serotonin reuptake inhibitors (SSRIs) including paroxetine and fluoxetine in postnatally depressed women (e.g. Appleby et al., 1997; Yonkers et al., 2008).”
BackgroundInterpersonal psychotherapy for postpartum depression: a systematic review
Miniati, M., Callari, A., Calugi, S., Rucci, P., Savino, M., Mauri, M., & Dell’Osso, L. (2014) · Archives of Women's Mental Health · doi:10.1007/s00737-014-0442-7 · Cited by 91
“The first open trial with IPT for PPD was a 12-week study on six patients who met the DSM-III-R criteria for a major depressive episode during the postpartum period (MDD) (Stuart and O’Hara 1995).”
InfluentialManagement of Postpartum Depression
Guille, C., Newman, R., Fryml, L. D., Lifton, C. K., & Epperson, C. N. (2013) · Journal of Midwifery & Women s Health · doi:10.1111/jmwh.12104 · Cited by 129
A randomized, placebo-controlled, double-blind trial of sertraline for postpartum depression
Hantsoo, L., Ward-O’Brien, D., Czarkowski, K. A., Gueorguieva, R., Price, L. H., & Epperson, C. N. (2014) · Psychopharmacology · doi:10.1007/s00213-013-3316-1 · Cited by 91
Maternal Depressive Symptoms, Employment, and Social Support
Gjerdingen, D., McGovern, P., Attanasio, L., Johnson, P. J., & Kozhimannil, K. B. (2014) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2014.01.130126 · Cited by 88
Group treatment for postpartum depression: a systematic review
Goodman, J. H., & Santangelo, G. (2011) · Archives of Women's Mental Health · doi:10.1007/s00737-011-0225-3 · Cited by 74
“Antidepressants can effectively decrease PPD symptoms (Cohen et al. 2001; Appleby et al. 1997; Yonkers et al. 2008; Wisner et al. 2006); however, many women are reluctant to take medication, even if not breastfeeding (Goodman 2009).”
BackgroundPostpartum depression among immigrant women
Fung, K. P.-L., & Dennis, C. (2010) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e32833ad721 · Cited by 99
Antidepressants for preventing postnatal depression
Molyneaux, E., Telesia, L. A., Henshaw, C., Boath, E., Bradley, E., & Howard, L. M. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004363.pub3 · Cited by 85
McDonagh, M. S., Matthews, A., Phillipi, C., Romm, J., Peterson, K., Thakurta, S., & Guise, J.-M. (2014) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000000410 · Cited by 77
Postpartum depression: psychoneuroimmunological underpinnings and treatment
Anderson, G., & Maes, M. H. J. (2013) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s25320 · Cited by 88
“The Yonkers et al study produced similar results.(75) These studies could suggest that psychotherapy would be the more efficacious and safer option.”
Ghasemi, M., Montaser‐Kouhsari, L., Shafaroodi, H., Nezami, B. G., Ebrahimi, F., & Dehpour, A. R. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1609-1 · Cited by 73
“panic disorder, and social anxiety (Anderson 2000; Ballus et al. 2000 ;B ourin et al.2001; Chaudhry et al. 2002 ;C laghorn et al.1992; Emslie et al. 2006 ;D anish University Antidepressant Group 1990 ;K eller et al.2001; Nemeroff 1993 ;R apaport et al.2003; Yonkers et al. 2008 ).”
BackgroundRundgren, S., Brus, O., Båve, U., Landén, M., Lundberg, J., Nordanskog, P., & Nordenskjöld, A. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.04.043 · Cited by 68
Pharmacokinetics of Sertraline Across Pregnancy and Postpartum
Freeman, M. P., Nolan, P. E., Davis, M. F., Anthony, M., Fried, K., Fankhauser, M., Woosley, R. L., & Moreno, F. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31818d2048 · Cited by 66
“In recent treatment studies in pregnant and postpartum women with MDD, researchers in this area have found that enrollment and retention are challenging in this population.(36,37) In a longitudinal study by Sit et al,(16) single blood samples were obtained longitudinally during pregnancy and postpartum.”
BackgroundPerinatal Dyadic Psychotherapy for postpartum depression: a randomized controlled pilot trial
Goodman, J. H., Prager, J., Goldstein, R., & Freeman, M. (2015) · Archives of Women's Mental Health · doi:10.1007/s00737-014-0483-y · Cited by 64
“Antidepressants can effectively decrease PPD symptoms (e.g., Cohen et al. 2001;Wisner et al. 2002; Yonkers et al. 2008); nevertheless, there is great reluctance among many postpartum women to take medication, even if not breastfeeding (Goodman 2009).”
Bloch, M., Meiboom, H., Lorberblatt, M., Bluvstein, I., Aharonov, I., & Schreiber, S. (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.11m07117 · Cited by 63
Gjerdingen, D. K., McGovern, P., Pratt, R., Johnson, L., & Crow, S. (2013) · Journal of Primary Care & Community Health · doi:10.1177/2150131912451598 · Cited by 61
Pharmacologic Treatment for Postpartum Depression: A Systematic Review
Ng, R. C., Hirata, C. K., Yeung, W., Haller, E., & Finley, P. R. (2010) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.30.9.928 · Cited by 63
“More recently, an 8-week randomized controlled trial was conducted to compare paroxetine (mean dose 21 mg/day) with placebo, with 35 subjects in each group.(54) Subjects were included if the onset of postpartum depression symptoms was within 3 months of delivery and depressive 935”
MethodResultVoluntary running influences the efficacy of fluoxetine in a model of postpartum depression
Gobinath, A. R., Richardson, R. J., Chow, C., Workman, J. L., Lieblich, S. E., Barr, A. M., & Galea, L. A. M. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.09.017 · Cited by 54
“…fluoxetine (FLX) in a rat model of PPD. Systematic reviews evaluating efficacy of postpartum use of selective serotonin reuptake inhibitors (SSRIs) suggest that these drugs are no more effective than placebo in mothers by 3e6 months postpartum (Yonkers et al., 2008; De Crescenzo et al., 2014).”
BackgroundDevelopment of neuroactive steroids for the treatment of postpartum depression
Gunduz‐Bruce, H., Takahashi, K. U., & Huang, M. (2021) · Journal of Neuroendocrinology · doi:10.1111/jne.13019 · Cited by 62
Postpartum Depression: Diagnostic and Treatment Issues
Sharma, V., & Sharma, P. (2012) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)35240-9 · Cited by 72
Navarre, B. M., Laggart, J. D., & Craft, R. M. (2010) · Physiology & Behavior · doi:10.1016/j.physbeh.2009.10.011 · Cited by 51
“The lack of efficacy of antidepressant treatment in HSP rats was surprising given that a majority of studies in women report a modest reversal or delayed recurrence of PPD symptoms following chronic antidepressant treatment [14,50,69,70].”
Antidepressant Treatment for Postnatal Depression
Molyneaux, E., Trevillion, K., & Howard, L. M. (2015) · JAMA · doi:10.1001/jama.2015.2276 · Cited by 46
Brexanolone for postpartum depression: clinical evidence and practical considerations
Leader, L. D., O'Connell, M., & VandenBerg, A. (2019) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2331 · Cited by 43
Pharmacotherapy of postpartum depression
di Scalea, T. L., & Wisner, K. L. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560903277202 · Cited by 42
“Randomized clinical trials (n = 5) Placebo control group = 3 [38, 40, 41] Active control group = 2 [37, 39] Randomized clinical trials (n = 3) Placebo control group = 3 [17, 25, 29] Active control group = 0 PPD empirical studies (n = 19) Treatment studies (n = 12) Prevention studies (n = 7) Open-label studies (n = 4)…”
BackgroundMethodInfluentialIdentification of bipolar disorder in women with postpartum depression
Sharma, V., & Khan, M. (2010) · Bipolar Disorders · doi:10.1111/j.1399-5618.2010.00809.x · Cited by 44
O'Hara, M. W., Pearlstein, T., Stuart, S., Long, J. D., Mills, J. A., & Zlotnick, C. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.10.361 · Cited by 39
Perinatal depression: Heterogeneity of disease and in animal models
Qiu, W., Hodges, T. E., Clark, E. L., Blankers, S. A., & Galea, L. A. M. (2020) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2020.100854 · Cited by 44
Shapiro, G. D., Fraser, W. D., & Séguin, J. R. (2012) · The Canadian Journal of Psychiatry · doi:10.1177/070674371205701108 · Cited by 44
Treatment of Postpartum Depression: Recommendations for the Clinician
O’Hara, M. W., & Engeldinger, J. (2018) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000353 · Cited by 40
Therapeutics of postpartum depression
Thomson, M., & Sharma, V. (2016) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2017.1265888 · Cited by 31
Li, H. J., Martinez, P. E., Li, X., Schenkel, L. A., Nieman, L. K., Rubinow, D. R., & Schmidt, P. J. (2019) · Archives of Women s Mental Health · doi:10.1007/s00737-019-00991-3 · Cited by 34
Are Antidepressants Effective in the Treatment of Postpartum Depression? A Systematic Review
Sharma, V., & Sommerdyk, C. (2013) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.13r01529 · Cited by 38
Adina, J., Morawska, A., Mitchell, A. E., & McBryde, M. (2021) · Clinical Child and Family Psychology Review · doi:10.1007/s10567-021-00371-3 · Cited by 30
Kaufman, Y., Carlini, S. V., & Deligiannidis, K. M. (2022) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253211065859 · Cited by 41
Antidepressant Treatment for Postnatal Depression
Molyneaux, E., Howard, L. M., McGeown, H. R., Karia, A. M., & Trevillion, K. (2017) · Issues in Mental Health Nursing · doi:10.1080/01612840.2016.1182409 · Cited by 25
Ahmadpanah, M., Nazaribadie, M., Aghaei, E., Ghaleiha, A., Bakhtiari, A., Haghighi, M., Bahmani, D. S., Akhondi, A., Bajoghli, H., Jahangard, L., et al. (2017) · Archives of Women s Mental Health · doi:10.1007/s00737-017-0753-6 · Cited by 30
“…of the administration of antidepressants such as SSRIs (Guille et al., 2013; Vigod and Stewart 2017), though, results from randomized clinical trials and open-label trials on the efficacy of SSRIs on PPD were mixed and not convincing (Yonkers et al., 2008; Bloch et al., 2012; Guille et al., 2013).”
BackgroundResultInfluentialZhang, Q., Dai, X., & Li, W. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.950004 · Cited by 32
“, 2021), and six were considered unclear risk of bias due to attrition bias (Yonkers et al., 2008; Bloch et al., 2012; O’Hara and McCabe, 2013; Hantsoo et al., 2014; Kashani et al., 2017; Li et al., 2020).”
BackgroundThe Development and Content of an Interpersonal Psychotherapy Group for Postnatal Depression
Reay, R. E., Mulcahy, R., Wilkinson, R. B., Owen, C. A., Shadbolt, B., & Raphael, B. (2012) · International Journal of Group Psychotherapy · doi:10.1521/ijgp.2012.62.2.221 · Cited by 25
Meltzer-Brody, S. E., Gerbasi, M. E., Mak, C., Toubouti, Y. M., Smith, S. C., Roskell, N., TAN, R. S.-H., Chen, S., & Deligiannidis, K. M. (2024) · Journal of Medical Economics · doi:10.1080/13696998.2024.2334160 · Cited by 34
“The mean (SD) HAMD-17 score for the placebo group in the Yonkers et al. study was 24.7 (5.0) 51 , which fell below the minimum HAMD-17 score ( � 26) required for inclusion in the SKYLARK Study 25 .”
InfluentialBiologically based treatment approaches to the patient with resistant perinatal depression
Robakis, T. K., & Williams, K. E. (2013) · Archives of Women s Mental Health · doi:10.1007/s00737-013-0366-7 · Cited by 20
Qiu, W., Duarte‐Guterman, P., Eid, R. S., Go, K. A., Lamers, Y., & Galea, L. A. M. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108174 · Cited by 19
Misri, S. K., Swift, E., Abizadeh, J., & Shankar, R. (2016) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125316656297 · Cited by 17
Viswanathan, M., Middleton, J. C., Stuebe, A. M., Berkman, N. D., Goulding, A. N., McLaurin‐Jiang, S., Dotson, A. B., Coker-Schwimmer, M. J. L., Baker, C., Voisin, C. E., et al. (2021) · Psychiatric Research and Clinical Practice · doi:10.1176/appi.prcp.20210001 · Cited by 19
“Anxiety Benzodiazepine Placebo, no treatment, or active treatment - - - - - - - - - - - Hydroxyzine Placebo, no treatment, or active treatment - I - - - - - - - - - All other anxiolytics Placebo, no treatment, or active treatment - - - - - - - - - - - Sedativesa Placebo, no treatment, or active treatment - - - - - - -…”
Peripartum management of bipolar disorder: what do the latest guidelines recommend?
Sharma, V., & Sharma, S. (2016) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2017.1243470 · Cited by 16
Treating Postpartum Depression: What Do We Know about Brexanolone?
Ali, M., Aamir, A., Diwan, M. N., Awan, H. A., Ullah, I., Irfan, M., & Berardis, D. D. (2021) · Diseases · doi:10.3390/diseases9030052 · Cited by 17
Uğuz, F., Akman, C., Şahingöz, M., Kaya, N., & Kucur, R. (2009) · Journal of Psychosomatic Obstetrics & Gynecology · doi:10.1080/01674820802545818 · Cited by 17
“Some authors suggested that patients with postpartum major depression treated with antidepressants had a significantly higher rate of remission, compared with the placebo group [32].”
BackgroundPerinatal mental health: advances and opportunities
Stowe, Z. N. (2023) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20230822 · Cited by 13
Smith, R. D., Dang, W., Shen, S., Hung, S. C., Ip, H. L., Kwok, J. Y. Y., Choi, E. P. H., Fong, D., Ali, S., Wilson, C. A., et al. (2024) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2024.104316 · Cited by 15
An update on the pharmacotherapy of postpartum depression
Arifunhera, J., & Ravichandran, M. (2024) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.15980 · Cited by 18
Zhou, Y.-M., Yuan, J.-J., Xu, Y.-Q., Gou, Y.-H., Zhu, Y. Y. X., Chen, C., Huang, X., Ma, X., Pi, M., & Yang, Z. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1228940 · Cited by 11
Advances in treatment for postpartum major depressive disorder
Amodeo, G., Laurenzi, P. F., Santucci, A., Cuomo, A., Bolognesi, S., Goracci, A., Rossi, R., Crescenzi, B. B., Neal, S. M., & Fagiolini, A. M. (2020) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2020.1779702 · Cited by 12
The Ties That Bind: Maternal-Infant Interactions and the Neural Circuitry of Postpartum Depression
Leibenluft, E., & Yonkers, K. A. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.10081159 · Cited by 10
“Psychopharmacologic studies in postpartum depression tend to assess the impact of treatment on the mother’s depression but not on mother-infant interactions (10, 11).”
BackgroundSelf-citationSecond-Generation Antidepressants in the Pharmacologic Treatment of Adult Depression
Gartlehner, G., Hansen, R. A., Morgan, L. C., Thaler, K. J., Lux, L. J., Noord, M. V., Mager, U., Gaynes, B. N., Thieda, P., Strobelberger, M., et al. (2011) · Cited by 8
Predictors of response to antidepressants in women with postpartum depression: a systematic review
Sharma, V., Khan, M., Baczynski, C., & Boate, I. (2020) · Archives of Women s Mental Health · doi:10.1007/s00737-020-01044-w · Cited by 9
The Effects of Ibuprofen Consumption on the Incidence of Postpartum Depression
Kapulsky, L., Christos, P. J., Ilagan, J., & Kocsis, J. H. (2021) · Clinical Neuropharmacology · doi:10.1097/wnf.0000000000000448 · Cited by 7
Evidence‐Based Treatments and Pathways to Care
O’Hara, M. W., Dennis, C., McCabe, J. E., & Galbally, M. (2015) · Wiley eBooks · doi:10.1002/9781118509722.ch11 · Cited by 7
Depressão pós-parto: tratamento baseado em evidências
Ibiapina, F. L. P., Alves, J. A. G., Busgaib, R. P. S., & Costa, F. D. S. (2010) · Cited by 14
Postpartum Depression: Advances in Recognition and Treatment
Suri, R., & Altshuler, L. L. (2012) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.10.1.15 · Cited by 5
Nair, B. (2014) · Springer eBooks · doi:10.1007/978-3-319-11005-9_31 · Cited by 2
Christian, S. (2013) · ScholarsArchive (Brigham Young University) · Cited by 2
Desórdenes psiquiátricos en el puerperio: nuestro papel como obstetras
Ríos, A. P., González, M. N., Benéitez, M. C. V., de la Cruz, A. A., & Quintana, L. O. (2013) · Clínica e Investigación en Ginecología y Obstetricia · doi:10.1016/j.gine.2013.10.001 · Cited by 10
An Analysis of Factors Affecting Postnatal Depression Intervention Adherence
Omisade, O., Good, A., Fitch, T., & Briggs, J. (2019) · IGI Global eBooks · doi:10.4018/978-1-7998-1204-3.ch047 · Cited by 2
An Analysis of Factors Affecting Postnatal Depression Intervention Adherence
Omisade, O., Good, A., Fitch, T., & Briggs, J. (2017) · International Journal of Public Health Management and Ethics · doi:10.4018/ijphme.2017010101 · Cited by 1
Treatment-resistant depression in pregnancy, the postpartum period, and transition to menopause
Kaufman, Y., Eichenbaum, R. M., Carlini, S. V., & Deligiannidis, K. M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824067-0.00037-2 · Cited by 1
Psychiatric Disorders in Pregnancy
Pearlstein, T. B., & Star, J. (2010) · Wiley eBooks · doi:10.1002/9781444323016.ch21
The development, treatment, and prevention of perinatal mood and anxiety disorders
Sockol, L. E. (2013) · Scholarly Commons (University of Pennsylvania)
A case of syndrome of inappropriate secretion of antidiuretic hormone associated with paroxetine
Ahn, H. J., Kim, H. W., Kim, Y. S., Kim, Y. O., Yoon, S. A., & Choi, J. K. (2010) · The Korean Journal of Internal Medicine · Cited by 1
Latha, S., Bellamkonda, G., & Viriti, U. S. (2016) · Pharmaceutical and Biological Evaluations · Cited by 1
Molecular basis of tryptophan metabolism disorders associated with depression
Wigner, P., Gałecki, P., & Śliwiński, T. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-817935-2.00019-2 · Cited by 2
Paroxetine 복용 후 발생한 항이뇨호르몬 분비이상 증후군 1예
안효준, 김형욱, 김영수, 김영옥, 윤선애, & 최재기 (2010) · Korean Journal of Medicine
An Analysis of Factors Affecting Postnatal Depression Intervention Adherence
Omisade, O., Good, A., Fitch, T., & Briggs, J. (2019) · IGI Global eBooks · doi:10.4018/978-1-7998-2351-3.ch014
Omisade, O., & Good, A. (2022) · International Journal of Applied Research on Public Health Management · doi:10.4018/ijarphm.315802
Pharmacotherapy of postpartum depression: An update
Kumar, K., Pallavi, K., Martand, K., & Maharshi, V. (2025) · Indian Journal of Obstetrics and Gynecology Research · doi:10.18231/j.ijogr.2025.001 · Cited by 1
Yang, Q., Lv, Y., Gao, S., Zhang, Y., & Zhai, X. (2025) · Frontiers in Psychology · doi:10.3389/fpsyg.2025.1529339
Sleep and Perinatal Major Depressive Disorder
Ganjavi, H., & MacDonald, P. A. (2025) · Springer eBooks · doi:10.1007/978-3-031-95948-6_5
Chatha, Z. F., Trinh, N. T., Rostami, S., Bergink, V., Carson, A. C., Magnus, P. M., & Lupattelli, A. (2026) · The European Journal of Psychiatry · doi:10.1016/j.ejpsy.2026.100352
First Reported Case of Dissociative Symptoms Associated With Zuranolone Use in Peripartum Depression
Ok, H. I., Mikkilineni, Y., Batheja, P., Manalai, N., Foroobar, A., Yanoff, B., Kumari, S., & Manalai, P. (2026) · Cureus · doi:10.7759/cureus.110076
“A randomized controlled trial investigating paroxetine demonstrated both clinically and statistically significant benefits in the treatment of PPD [12].”
Metadata
- Authors
- Yonkers, K. A., Lin, H., Howell, H. B., Heath, A. C., & Cohen, L. S.
- Affiliations
- Yale University (US)
- Harvard University (US)
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2008-04-15
- Volume
- 69
- Issue
- 4
- Pages
- 659-665
- ISSN
- 0160-6689 (ISSN-L)
- PMC
- PMC3073141
- OpenAlex
- W2016972223
- Cited by
- 98
- References
- 23
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 3 · 2023: 2 · 2022: 4 · 2021: 7 · 2020: 6 · 2019: 7 · 2018: 6 · 2017: 3 · 2016: 5 · 2015: 3 · 2014: 6 · 2013: 11 · 2012: 7
- FWCI
- 7.62
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Mental Health (K08MH001908, MH01648, R21MH080959)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Keywords
- postpartum depression, major depressive disorder, paroxetine, antidepressant treatment, remission, adverse effects
- MeSH terms
- Adult, Breast Feeding, Demography, Depressive Disorder, Major, Major Depressive Disorder, Female, Humans, Surveys and Questionnaires, Selective Serotonin Reuptake Inhibitors, Paroxetine, Depression, Postpartum, Diagnostic and Statistical Manual of Mental Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.